Back to search
FDAFDA · Food and drugs·Recall number D-1142-2023

Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactured by: Patheon, Cincinnati, OH 45237, NDC 67386-211-65

Published September 6, 2023 · Recall initiated: August 17, 2023

Summary

FDA records drug Class III recall D-1142-2023, published September 6, 2023 and initiated August 17, 2023. Recalling firm: Lundbeck LLC; Status: Completed; Reported quantity: 10,543 cartons; Lot: Lot#: 3207333A, 3207334A, Exp 03/2027; 3214707A, 3214709A, 3214710A, Exp 02/2028 . Class III means the product is not likely to cause adverse health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross contamination with other products

What to do

Voluntary: Firm initiated · Letter

Get an email if SABRIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SABRIL
Manufacturer
Lundbeck LLC
Distributor
Nationwide within the U.S.
Lot
Lot#: 3207333A, 3207334A, Exp 03/2027; 3214707A, 3214709A, 3214710A, Exp 02/2028 .
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactured by: Patheon, Cincinnati, OH 45237, NDC 67386-211-65 recalled?

Yes. FDA published recall D-1142-2023 on September 6, 2023. Reported hazard: Cross contamination with other products

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SABRIL.